As the HR goes up, we can see that the survival rate goes up, and higher mRNA expression of FMNL1 also resulted in increased survival rate (Figures 4(a), 4(d), and 4(g)), and FMNL2 (Figures 4(b), 4(e), and 4(h)) was significantly associated with better probability of BrCa patients. This evidence concerns the gene FMNL2 and invasive breast carcinoma.